MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

MDSpire News

  • August 20, 2026
FDA approves garetosmab for adults with FOP
  • Kathryn Wighton
  • August 20, 2026
  • 3 min
  1. The FDA approved garetosmab for adults with fibrodysplasia ossificans progressiva to reduce new heterotopic ossification lesions.
  2. The recommended starting dose of garetosmab is 10 mg/kg, administered intravenously every 4 weeks.
  3. The approval was based on findings from the phase 3 OPTIMA trial, which involved 63 adults with FOP.
  4. Patients receiving garetosmab 10 mg/kg had a 90% reduction in new HO lesions compared to placebo.
  5. Adverse reactions in garetosmab-treated patients included abscess, acne, and increased hair growth, among others.
...more

MDSpire News

  • August 20, 2026
FDA approves therapy for GSDIa
  • Kathryn Wighton
  • August 20, 2026
  • 2 min
  1. The FDA granted accelerated approval to pariglasgene brecaparvovec-opnr (Genglycos) for glycogen storage disease type Ia.
  2. This therapy aims to reduce daily cornstarch intake in patients aged 8 years and older as part of nutritional management.
  3. Pariglasgene brecaparvovec-opnr is a gene therapy designed to deliver a functional glucose-6-phosphatase gene to the liver.
  4. Clinical trials showed a 31% mean reduction in daily cornstarch intake among treated patients compared to placebo.
  5. Serious adverse reactions include anaphylaxis and adrenal insufficiency, with warnings included in the prescribing information.
...more

MDSpire News

  • August 20, 2026
Leflunomide eyed for steroid-sparing ICANS care
  • Andrea Surnit
  • August 20, 2026
  • 5 min
  1. Leflunomide is identified as a prototype candidate for managing immune effector cell-associated neurotoxicity syndrome (ICANS) following CAR T-cell therapy.
  2. The proposed mechanism involves mitochondrial dysfunction amplifying neuroinflammation, which is not adequately addressed by current steroid-based treatments.
  3. Leflunomide's active metabolite, teriflunomide, inhibits DHODH, affecting mitochondrial reactive oxygen species and inflammatory pathways.
  4. The authors suggest a staged evaluation pathway for leflunomide, starting with preclinical studies and leading to randomized clinical trials.
  5. Current management of ICANS primarily relies on corticosteroids, which may not be effective for all patients and can lead to adverse effects.
...more

Kff Health News

  • August 20, 2026
How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages
  • Arthur Allen
  • August 20, 2026
  • 15 min

Objective: To explore the challenges and implications of FDA-approved dosages of cancer drugs, particularly in light of patient experiences and emerging researc

...more

MDSpire News

  • August 20, 2026
Spondyloarthritis function varies by sex
  • Kathryn Wighton
  • August 20, 2026
  • 4 min

Objective: To evaluate functional deterioration and work disability in men and women with spondyloarthritis over a 17-year period. Approach: Study Design: A lon

...more

MDSpire News

  • August 20, 2026
Targeted therapy tested in dermatomyositis
  • Kathryn Wighton
  • August 20, 2026
  • 4 min
  1. Brepocitinib 30 mg daily significantly improved Total Improvement Scores in dermatomyositis patients compared to placebo in a phase 3 trial.
  2. The VALOR trial involved 241 adults with active muscle and skin disease, randomized to receive brepocitinib or placebo for 52 weeks.
  3. At week 52, 68% of patients on brepocitinib 30 mg achieved moderate improvement, compared to 44% on placebo.
  4. Serious infections were more common in the brepocitinib 30 mg group, occurring in 10% of patients versus 1% in the placebo group.
  5. The study was funded by Priovant Therapeutics, and no mortality events or opportunistic infections were reported during the trial.
...more

MDSpire News

  • August 20, 2026
Ralinepag in pulmonary arterial hypertension
  • Kathryn Wighton
  • August 20, 2026
  • 5 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

MDSpire News

  • August 20, 2026
Medical Oddities: Sheep wool gets into bone repair
  • Teraya Smith
  • August 20, 2026
  • 5 min

Objective: To test keratin-based membranes derived from sheep wool as an alternative to collagen for guided bone regeneration. Approach: Cell Viability Testing:

...more

The Pathologist

  • August 20, 2026
Measles Outbreaks Are a Lab Wake-Up Call
  • Jessica Allerton
  • August 20, 2026
  • 8 min

Objective: To highlight the challenges and necessary improvements in laboratory response to measles outbreaks in the US, particularly in the context of declinin

...more

The Pathologist

  • August 20, 2026
A Closer Look at the Complete Genome
  • August 20, 2026
  • 3 min
  1. Researchers developed a nearly complete diploid genome benchmark to improve genomic analysis methods.
  2. The study focused on HG002, a reference sample from the Genome in a Bottle Consortium, covering 99.4% of the diploid genome.
  3. The new T2T-HG002 benchmark added 701.4 Mb of high-confidence sequence, including both sex chromosomes.
  4. Genome Quality Checker software was created to evaluate sequencing methods against the diploid benchmark.
  5. The benchmark aids in assessing genomic assays in challenging regions, though it is not error-free and lacks standardized metrics.
...more

The Ophthalmologist

  • August 20, 2026
WaveFront Dynamics Expands Scleral Lens Options With Two New Integrations
  • August 20, 2026
  • 2 min

Objective: To provide eye care professionals with greater flexibility in premium scleral lens selection and patient care through new integrations. Approach: Col

...more

The Ophthalmologist

  • August 20, 2026
Early Warning in Young Eyes
  • August 20, 2026
  • 3 min
  1. Retinal neurodegeneration may be detectable in youth with type 1 diabetes before clinically apparent diabetic retinal disease emerges.
  2. The study analyzed 294 young participants with type 1 diabetes, focusing on retinal layer thickness and glycemic outcomes.
  3. Higher HbA1C levels were associated with thinner ganglion cell and outer retinal layers in participants.
  4. The presence or severity of diabetic retinal disease was not significantly associated with total retinal thickness.
  5. The findings suggest that OCT may help identify young patients with subclinical retinal changes before visible disease appears.
...more

The Analytical Scientist

  • August 20, 2026
Can Blood Filtration Reduce PFAS?
  • August 20, 2026
  • 3 min

Objective: To investigate whether therapeutic apheresis can reduce circulating PFAS and microplastic-related signals in patients. Approach: Study Design: The st

...more

The Medicine Maker

  • August 20, 2026
Musings from The Power List: Daniel Vitt
  • Daniel Vitt
  • August 20, 2026
  • 7 min
  1. Immunic closed a $400 million private placement financing to support Phase 3 trials in multiple sclerosis and transition to a commercial neurology company.
  2. Small molecules remain crucial in targeting intracellular pathways, particularly in conditions like multiple sclerosis, due to their practical advantages.
  3. Early small-molecule discovery is accelerating through AI and advanced screening technologies, enhancing the efficiency of candidate identification.
  4. Drug development faces complexity from stringent clinical trial requirements and evolving regulations, necessitating smarter trial designs and better data use.
  5. Expanding biomarker-based trial endpoints could streamline drug approvals, reduce costs, and enhance competition in pharmaceutical research and development.
...more

Archives Of Orthopaedic And Trauma Surgery

  • August 20, 2026
Feasibility Study on the Introduction and Initial Outcomes of Same-Day Hip and Knee Replacement Surgery in a Public Hospital Lacking Prior Experience
  • Christoffer C. Jørgensen
  • Thor-Magnus Sveen
  • Brita Johansen
  • Marlene Sander
  • Christian Steen-Hansen
  • Mikkel S. Sundstrup
  • Christian Rothe
  • Kai HW. Lange
  • August 20, 2026
  1. Total knee and hip replacements are increasingly common, with public healthcare systems facing resource constraints.
  2. The Danish Center for Fast-track Hip and Knee Replacement reported a 95% integration rate for eligible patients into the same-day surgery pathway.
  3. The feasibility study evaluates the implementation and outcomes of same-day surgery for hip and knee replacements in a public hospital.
  4. Data collection included patient-reported outcomes and electronic health records, assessing satisfaction and postoperative interactions.
  5. The study utilized the Bowen framework for feasibility studies, focusing on dimensions like acceptability and implementation.
...more

Food Safety And Risk

  • August 20, 2026
Evaluation of Raw Milk Quality and Water Contamination in the Dairy Value Chain of West Hararghe Zone, Eastern Ethiopia
  • Nuredin Seid Ali
  • Teressa Fekata Jebessa
  • Workneh Ensermu Bayisa
  • August 20, 2026
  1. Ethiopia produces approximately 3.32 billion liters of cow milk annually, accounting for 91% of the country's total milk production.
  2. Milk quality is threatened by natural deterioration and deliberate adulteration, with water addition being the most common method.
  3. Adulterated milk poses public health risks due to potential contamination from pathogenic microorganisms and chemical substances.
  4. About 95% of marketed milk in Ethiopia flows through informal value chains, facing challenges like inadequate regulatory enforcement and quality control.
  5. The study aimed to assess raw milk's chemical composition and the prevalence of water adulteration in the West Hararghe Zone of Eastern Ethiopia.
...more

Jama Network Open

  • August 20, 2026
Identifying Beneficiaries of Accountable Care Organizations
  • Peter M. Hoang
  • Elbert S. Huang
  • August 20, 2026

Objective: To investigate whether the establishment of accountable care organizations (ACOs) leads to a differential reduction in healthcare utilization between

...more

Frontiers In Endocrinology

  • August 20, 2026
Anterior Neck Dysfunction Following Thyroid Surgery: Clinical Profiles, Underlying Mechanisms, and Holistic Management Approaches
  • Xiaokang Liu
  • Yu Li
  • Qiang Ma
  • Lijuan An
  • Liang Guo
  • August 20, 2026
  1. Post-thyroidectomy anterior neck dysfunction encompasses symptoms like neck pain, voice changes, and swallowing difficulties.
  2. This dysfunction arises from disturbances in the anterior neck functional network during thyroid surgery.
  3. The review synthesizes literature on clinical phenotypes, risk factors, and management strategies related to this dysfunction.
  4. The proposed framework is not a formally recognized diagnosis but aims to guide clinical interpretation and future research.
  5. Symptoms of anterior neck dysfunction can significantly impact quality of life, even in the absence of major surgical complications.
...more